Essential Partners
AURA icon

Essential Partners’s Aura Biosciences AURA Stock Holding History

Essential Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$446 Sell
71
-45
-39% -$322 ﹤0.01% 2431
2026
Q2 		$824 Sell
116
-431
-79% -$3.08K ﹤0.01% 2329
2026
Q1 		$3.66K Buy
+547
New +$3.14K ﹤0.01% 1727

Other funds holding AURA

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Essential Partners's AURA Position: Q3 2026 in Review

Essential Partners reduced its Aura Biosciences (AURA) stake by 39% in Q3 2026, selling an estimated $322 and leaving 71 shares worth $446. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Essential Partners first reported a position in AURA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.66K in Q1 2026. 18 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Essential Partners held 71 shares of Aura Biosciences worth $446 as of Q3 2026.
  • Essential Partners sold 45 Aura Biosciences shares in Q3 2026, an estimated $322.
  • Aura Biosciences made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2431 holding.
  • Essential Partners first reported a position in Aura Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Essential Partners's Aura Biosciences position peaked at $3.66K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.